CRP and metabolic syndrome: Additionally controlling for inflammatory markers (CRP, IL-6, LBP) (model 3) and HMW-adiponectin (model 4), the ORs of MetS and its components (elevated blood pressure and low HDL cholesterol) were attenuated slightly, but remained significant.